Medicenna Therapeutics Stock Forecast

TSX-MDNA's stock price has decreased by -54.6% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Medicenna Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $2.80. The average 1-year stock price forecast is 636.84% higher than the current stock price, while the lowest is $1.60 (+321.05%) and the highest is $4.00 (+952.63%).

Price Target: $2.80 (+636.84%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.60	$2.80	$2.80	$4.00
Change	+321.05%	+636.84%	+636.84%	+952.63%

Analyst Ratings

The average analyst rating for Medicenna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Apr '26	Jun '26	Jul '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andre Uddin Research Capital	Research Capital	Buy Maintains $3.75 → $1.60	Buy	Maintains	$3.75 → $1.60	+321.05%	Jun 29, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

6.44M

EPS This Year

0.60

EPS Next Year

0.72

from 0.60

20.00%

from 0.60

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	-	-	-	-	-
Operating Income	-22.47M	-16.30M	-18.67M	-20.41M	-22.42M	-35.29M
Net Income	-22.58M	-10.05M	-25.47M	-11.81M	-18.41M	-33.94M
EPS	-	-	-	-	-	0.60
Forward PE	-	-	-	-	-	0.63
Free Cash Flow	-15.14M	-4.41M	-13.86M	-10.24M	-10.07M	-57.30M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

EPS	2027	2028	2029
High	0.60
Avg	0.60
Low	0.60

EPS Growth

EPS Growth	2028	2029
High	20.0%
Avg	20.0%
Low	20.0%